))
E130: Longevity Leader, Visual Storytelling, and Satellite Buses
Manage episode 431769476 series 3379164
Content provided by Sam Gordon and Brandon Osian. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sam Gordon and Brandon Osian or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Our Social Media Pages, follow us and engage with the Pill-grim community!
Join our Entre Community
And now for this week’s prescription:
On this week’s dose, we start (1:50) with a breakdown on Function Health, a startup that aims to empower people to live 100 healthy years through its comprehensive lab tests and personalized health dashboard, and their hearty $53M Series A. Then (10:15), we discuss HeyGen, a startup that’s looking to scale visual storytelling for businesses, hot off a $60M Series A. Lastly (18:09), we wrap up this week’s dose with a deepdive on Apex, a Los Angeles-based satellite manufacturing startup that secured a $95 million Series B to accelerate production of its "productized" satellite buses.
Sources:
https://www.functionhealth.com/
https://athletechnews.com/longevity-startup-function-raises-53m-for-personalized-health-testing/
https://www.heygen.com/article/announcing-our-series-a
https://www.maginative.com/article/ai-video-startup-heygen-raises-60-million-valued-at/
https://techcrunch.com/2024/06/11/apex-raises-95m-to-scale-satellite-bus-production/
https://spacenews.com/apex-raises-95-million-to-increase-satellite-bus-production/
Music Credit: Chapter One by Cole Bauer and Dean Keeton
https://www.instagram.com/deankeeton/?hl=en
Disclosure:
The views, statements, and opinions, expressed herein by the hosts and guests are their own, and their appearance on the podcast should not be construed as reflecting the views or implied endorsement of Independent Brokerage Solutions LLC or any of its officers, employees, or agents. The statements made herein should not be considered an investment opinion, advice, or a recommendation regarding securities of any company. This podcast is produced solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy a security.
137 episodes
Share
